Dark | Light
# ![@3IDWarrant Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1586375355681619969.png) @3IDWarrant Chris

Chris posts on X about $arwr, $alny, $srpt, $nvs the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: undefined [#](/creator/twitter::1586375355681619969/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1586375355681619969/c:line/m:interactions.svg)

- [--] Week [---] -81%
- [--] Month [-----] -68%
- [--] Months [------] +46%
- [--] Year [------] +37%

### Mentions: undefined [#](/creator/twitter::1586375355681619969/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1586375355681619969/c:line/m:posts_active.svg)

- [--] Month [--] -86%
- [--] Months [--] +30%
- [--] Year [---] +8.30%

### Followers: [---] [#](/creator/twitter::1586375355681619969/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1586375355681619969/c:line/m:followers.svg)

- [--] Week [---] +0.59%
- [--] Month [---] -0.58%
- [--] Months [---] +60%
- [--] Year [---] +98%

### CreatorRank: undefined [#](/creator/twitter::1586375355681619969/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1586375355681619969/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  49% [finance](/list/finance)  5% [cryptocurrencies](/list/cryptocurrencies)  3% [exchanges](/list/exchanges)  1%

**Social topic influence**
[$arwr](/topic/$arwr) 90%, [$alny](/topic/$alny) 18%, [$srpt](/topic/$srpt) 16%, [$nvs](/topic/$nvs) 14%, [$drna](/topic/$drna) 10%, [$ions](/topic/$ions) 8%, [$lly](/topic/$lly) 8%, [$wve](/topic/$wve) 8%, [arwr](/topic/arwr) 8%, [$nvo](/topic/$nvo) 5%

**Top accounts mentioned or mentioned by**
[@arrowheadpharma](/creator/undefined) [@rnaianalyst](/creator/undefined) [@hulksmash8181](/creator/undefined) [@bioboyscout](/creator/undefined) [@bikerieder](/creator/undefined) [@oligobio](/creator/undefined) [@medstudentinvst](/creator/undefined) [@jpmorgan](/creator/undefined) [@pawcio2009](/creator/undefined) [@elilillyandco](/creator/undefined) [@jmaraganore](/creator/undefined) [@wallstlobo](/creator/undefined) [@pt117cool](/creator/undefined) [@markclvb](/creator/undefined) [@biotech2k1](/creator/undefined) [@mooktrader](/creator/undefined) [@mykec382023](/creator/undefined) [@cloisterres](/creator/undefined) [@biomedicalrx](/creator/undefined) [@partimefriend](/creator/undefined)

**Top assets mentioned**
[Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Novartis AG (NVS)](/topic/$nvs) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Eli Lilly and Company (LLY)](/topic/$lly) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Novo-Nordisk (NVO)](/topic/$nvo) [Amgen, Inc. (AMGN)](/topic/$amgn) [Abivax SA (ABVX)](/topic/$abvx) [Smart Layer Network (SLN)](/topic/$sln) [Synthetify (SNY)](/topic/$sny) [Genelux Corporation (GNLX)](/topic/genelux-corporation) [Metsera, Inc. (MTSR)](/topic/$mtsr) [BEAM (BEAM)](/topic/$beam) [GSK plc (GSK)](/topic/$gsk) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Pfizer, Inc. (PFE)](/topic/$pfe) [Johnson & Johnson (JNJ)](/topic/$jnj) [Vertex Protocol (VRTX)](/topic/$vrtx)
### Top Social Posts
Top posts by engagements in the last [--] hours

"@EliLillyandCo scientist was pretty spot on [--] months ago describing the siRNA "Domino effect" for extra Hepatic delivery. @ArrowheadPharma has certainly proven out this rapid unlocking of tissue types like no other $ARWR $ALNY $IONS $SLN $LLY $NVO $NVS https://share.google/1yEyKlbXYXt0Sqk6s https://share.google/1yEyKlbXYXt0Sqk6s"  
[X Link](https://x.com/3IDWarrant/status/2012118520130052404)  2026-01-16T11:03Z [---] followers, [----] engagements


"$ARWR CEO webcast 2.25B cash on hand.literally too many opportunities to speak on.Expect EU partner(s).God is amazing"  
[X Link](https://x.com/3IDWarrant/status/2010747073675550912)  2026-01-12T16:13Z [---] followers, [----] engagements


"@RNAiAnalyst When I start to chase the wide array our bodies store fat the more and more the post GLP-1 world looks like it could be a botox type environment applicable to every person if interested for reason $WVE $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2017180037376590169)  2026-01-30T10:16Z [---] followers, [---] engagements


"@RNAiAnalyst Garnering 1-2B per target pretty much unanimously these days for an siRNA molecule it is still astounding to me that a more reputable RNAi co has not been transacted $ALNY $IONS $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2018404696881242455)  2026-02-02T19:22Z [---] followers, [----] engagements


"$ARWR $SRPT"  
[X Link](https://x.com/3IDWarrant/status/1937475848837226715)  2025-06-24T11:40Z [---] followers, [----] engagements


"@MookTrader Nope Yet that market metrics has remained irrational longer than most have remained solvent time for betterment I suppose $ALNY $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1937602652956680379)  2025-06-24T20:04Z [---] followers, [---] engagements


"$SRPT is reinventing itself on the back of $ARWR talk about a dedicated partner moving forward"  
[X Link](https://x.com/3IDWarrant/status/1945796220598816834)  2025-07-17T10:42Z [---] followers, [----] engagements


"Today watching $ARWR was the perfect example of how a stock can be manipulated down with little effort all but guaranteed those [--] calls are safe ๐Ÿ‘"  
[X Link](https://x.com/3IDWarrant/status/1946298367388139958)  2025-07-18T19:57Z [---] followers, [---] engagements


"Interestingly enough if $SRPT & $ARWR deal were to be renegotiated $ARWR would walk away with exceptional terms on profit share without a doubt"  
[X Link](https://x.com/3IDWarrant/status/1946729396431097859)  2025-07-20T00:30Z [---] followers, [----] engagements


"@MykeC382023 If $SRPT fate happens to be as you describe @ArrowheadPharma may have had the luckiest funding round in history if they see a return of assets $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1946744821839741163)  2025-07-20T01:31Z [---] followers, [---] engagements


"@CloisterRes That scenario that so many are calling likely for $SRPT would equate to the craziest bio bucks lotto win for $ARWR clinically derisked every day that goes by"  
[X Link](https://x.com/3IDWarrant/status/1948133360431182228)  2025-07-23T21:29Z [---] followers, [---] engagements


"@JMaraganore Amazing problems to have $ALNY"  
[X Link](https://x.com/3IDWarrant/status/1951278030145409348)  2025-08-01T13:45Z [---] followers, [---] engagements


"$SRPT guided lots & lots of siRNA data to close out [----] very excited to see how some of these programs perform in the clinic $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1953403560160358645)  2025-08-07T10:31Z [---] followers, [----] engagements


"@BiomedicalRX @ArrowheadPharma Anyone that was serious about an $ALNY BD Trans watched it stretch to the stratosphere no reason $ARWR with same capability can't achieve even 1/2 that (30B MC) in the coming years"  
[X Link](https://x.com/3IDWarrant/status/1953859391456718930)  2025-08-08T16:42Z [---] followers, [---] engagements


"$LLY & $ALNY action seems about right"  
[X Link](https://x.com/3IDWarrant/status/1957602926542663844)  2025-08-19T00:38Z [---] followers, [--] engagements


"Just Wow Congratulations @ArrowheadPharma $ARWR & $NVS coming together on a target is an amazing BD advancement for Arrowhead"  
[X Link](https://x.com/3IDWarrant/status/1962851932323676443)  2025-09-02T12:15Z [---] followers, [---] engagements


"@RNAiAnalyst $NVS clearly see advantages with $ARWR CNS platform this certainly better validates to me that @ArrowheadPharma CEO talking about cracking the BBB has credence SubQ non the less"  
[X Link](https://x.com/3IDWarrant/status/1962852697767289157)  2025-09-02T12:18Z [---] followers, [---] engagements


"Believe the $NVS $ARWR deal was to get the foot in the door for next year's sHTG readout I continue to believe more siRNA cardio drugs makes sense for $NVS to sell along side Leqvio"  
[X Link](https://x.com/3IDWarrant/status/1962912669486244330)  2025-09-02T16:17Z [---] followers, [---] engagements


"Zero knock to $ALNY but seeing $SNY & $NVS willing to partner with both $ALNY & $ARWR makes me feel RNAi BD is no longer a winner-take-all space each has advanced the tech to provide a worthy investment from pharma"  
[X Link](https://x.com/3IDWarrant/status/1962924471125197002)  2025-09-02T17:03Z [---] followers, [---] engagements


"NVS coming to $ARWR now for CNS validates for me the same way $AMGN came for Olpasiran in [----] im at an enjoy the bumpy ride up phase way too much unfolding over next [--] months just for @ArrowheadPharma let alone the partners who are clearly lining up to do buisness"  
[X Link](https://x.com/3IDWarrant/status/1963042546160214082)  2025-09-03T00:53Z [---] followers, [----] engagements


"@RNAiAnalyst $NVS spread the wealth approach across various RNAi platform companies sure seems like they are digging in for longer term platform shopping their backseat very large entry has their hands in nearly every RNAi Co pocket $ARWR $ALNY $IONS"  
[X Link](https://x.com/3IDWarrant/status/1963298717437485139)  2025-09-03T17:51Z [---] followers, [---] engagements


"@wallstlobo @hulksmash8181 If $ARWR CEO is correct (Cantor presentation) that most don't meet goal ( Trigs Below 880)on Olzarsiran then @ArrowheadPharma has great pricing power plus the "lead" will allow.did not meet trig goal to be established for payors. The lead may well work out nicely for $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1963953354943390172)  2025-09-05T13:12Z [---] followers, [---] engagements


"@Partimefriend @wallstlobo @hulksmash8181 @ArrowheadPharma @ArrowheadPharma CEO at Cantor made me think they may engage sHTG differently than previously thought CEO gave slight glimpse into a different angle they may explore to target a more narrow pop allowing price to remain high and be drug of choice $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1963981877741527162)  2025-09-05T15:05Z [---] followers, [---] engagements


"ARO-MAPT Will it work.man I hope so.the enabling of such advancements are undoubtedly the hand of God @ArrowheadPharma scientists are working $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1965748559992742368)  2025-09-10T12:05Z [---] followers, [---] engagements


"Congrats to @ArrowheadPharma previous VP of Finance $ARWR WESTLAKE VILLAGE Calif. Feb. [--] [----] (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX) a late clinical-stage immuno-oncology company today announced . https://finance.yahoo.com/news/genelux-corporation-announces-chief-financial-114500658.html https://finance.yahoo.com/news/genelux-corporation-announces-chief-financial-114500658.html"  
[X Link](https://x.com/3IDWarrant/status/1887207542788374877)  2025-02-05T18:31Z [---] followers, [---] engagements


"$MTSR Now $ABVX the open dialogue that seems to be a near transparent process in M&A all off a sudden is an absolute welcome breath of fresh air ๐Ÿ˜…๐Ÿ˜…$XBI $IBB"  
[X Link](https://x.com/3IDWarrant/status/2003969590444077266)  2025-12-24T23:22Z [---] followers, [---] engagements


"@RNAiAnalyst Reminds me of $DRNA after their PH readout followed by their acquisition. $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1612748511321415681)  2023-01-10T09:49Z [---] followers, [---] engagements


"@BikeRieder This is why personally speaking it's time to SUCCESSFULLY Exit and let a pharma take this modality where it wants to go. This story is inevitably turning into a $DRNA twin. $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1666378049078607873)  2023-06-07T09:34Z [---] followers, [---] engagements


"@BikeRieder Those are absolute facts leading to the here & now. How that potential is bargained/leveraged going forward to cover the finish is my $DRNA Comp"  
[X Link](https://x.com/3IDWarrant/status/1666401991281573897)  2023-06-07T11:09Z [---] followers, [---] engagements


"Good $ALNY thread. They were clearly embraced as a WS darling your reasoning while sounding great never applied to $ARWR a near identical CO. Dangerous logic. 9) Upon further review I would edit my 15b comment on $BEAM and increase it to 20-25b. If $ALNY can hit close to 17b [--] years before any FDA approvals BEAM should be capable of 20-25b before their first approval. I do think NTLA will lead the next [--] yrs then BEAM will take over 9) Upon further review I would edit my 15b comment on $BEAM and increase it to 20-25b. If $ALNY can hit close to 17b [--] years before any FDA approvals BEAM should"  
[X Link](https://x.com/3IDWarrant/status/1696657060589350913)  2023-08-29T22:52Z [---] followers, [----] engagements


"@TOWiU2 @1111DLH61 @RNAiAnalyst $ALNY & $DRNA $NVO Have now crossed the finish line. Fully acknowledge @ArrowheadPharma long road but there is no reason their FCS Drug not only gets there but establishes a high standard $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1709137865517453797)  2023-10-03T09:26Z [---] followers, [---] engagements


"I now view $LLY as another excellent move forward partner for $ARWR across their broad pipeline. Many synergies and left out in the $DRNA $NVO Marriage"  
[X Link](https://x.com/3IDWarrant/status/1709882987989323982)  2023-10-05T10:47Z [---] followers, [---] engagements


"@pt117cool Those are all true but it is certainly worth more than $DRNA sale price with lung tox clearing the way and many late(r) stage assets $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1730245768009629972)  2023-11-30T15:21Z [---] followers, [---] engagements


"@RNAiAnalyst The way $NVS continues limping into RNAi while footing large pop Leqvio has made little sense to me as an "Efficiency" story. $ALNY & $ARWR a bridge too wide"  
[X Link](https://x.com/3IDWarrant/status/1746102136839008383)  2024-01-13T09:29Z [---] followers, [---] engagements


"@RNAiAnalyst @biochemyst1 $LLY was a bidder for $DRNA but lost out to $NOVO what are your thoughts on $ALNY here"  
[X Link](https://x.com/3IDWarrant/status/1747369767088824658)  2024-01-16T21:26Z [---] followers, [---] engagements


"@MarkC_LVB @JMaraganore @matthewherper @EliLillyandCo $LLY was a bidder in the $DRNA acquisition $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1823778874238394494)  2024-08-14T17:49Z [---] followers, [---] engagements


"@hulksmash8181 @RNAiAnalyst After $LLY missed out on $DRNA and one of @ArrowheadPharma lead siRNA scientists moved over some form of $ARWR relationship seemed in bound"  
[X Link](https://x.com/3IDWarrant/status/1854559826057081069)  2024-11-07T16:21Z [---] followers, [---] engagements


"@Biotech2k1 @wkissel Does your analysis assign value only to clinical candidates If so I fully understand but the $11B $SRPT deal largely monetizes on the R&D side $ARWR At large can now R&D for specialty pharmas.or not the capacity is already built-in"  
[X Link](https://x.com/3IDWarrant/status/1863884872873328988)  2024-12-03T09:55Z [---] followers, [---] engagements


"@WallStPirate We are like-minded in that same view fully funded with the $SRPT deal & NDA filed for a clear winner it's time for the science to take center stage $ARWR requires the patience of a corpse"  
[X Link](https://x.com/3IDWarrant/status/1865327731430301715)  2024-12-07T09:29Z [---] followers, [---] engagements


"@hulksmash8181 With every day that goes by post the $SRPT deal such a low $ARWR valuation looks more and more attractive"  
[X Link](https://x.com/3IDWarrant/status/1866976830319890886)  2024-12-11T22:42Z [---] followers, [---] engagements


"@BikeRieder It would be pretty wild if the $SRPT CEO ended up as the Chair of $ARWR Board"  
[X Link](https://x.com/3IDWarrant/status/1869353933699002735)  2024-12-18T12:08Z [---] followers, [---] engagements


"@bioinvestor24 I don't know how $NVO is so "Lost" they bought $DRNA and have @ArrowheadPharma very talented old CSO it boggles me why they are not pushing next generation muscle sparring drugs into clinic via siRNA $ALNY $ARWR $WVE"  
[X Link](https://x.com/3IDWarrant/status/1874800535444082757)  2025-01-02T12:50Z [---] followers, [---] engagements


"It feels like at large shorting across $XBI biotech names has ushered high complacency levels with very weak out dated narratives $ARWR prime example"  
[X Link](https://x.com/3IDWarrant/status/1889709496634642558)  2025-02-12T16:13Z [--] followers, [----] engagements


"@hulksmash8181 @ArrowheadPharma currently sits at the highest institutional holding on record price should start to reflect such a following $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1890744052036825365)  2025-02-15T12:44Z [--] followers, [---] engagements


"@hulksmash8181 @ArrowheadPharma Apologies I meant holistically highest percentage being owned broadly by institutions overall percentage has never been this high clearly confidence & price need to talk and I'm sure they will $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1890780608235741434)  2025-02-15T15:10Z [--] followers, [---] engagements


"@ErvinBrent That's certainly interesting and could act as a pseudo buy back program supporting $ARWR if $SRPT likes what they see and the market continues to disregard @ArrowheadPharma"  
[X Link](https://x.com/3IDWarrant/status/1890781740597191026)  2025-02-15T15:14Z [--] followers, [---] engagements


"@ArrowheadPharma ALK7 data released today further shows an undervalued bio that has been bruised battered & past over $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1894371363713921123)  2025-02-25T12:58Z [--] followers, [---] engagements


"@BikeRieder $ARWR has great potential to be a real next player in obesity with next gen compounds in addition to $NVO $LLY"  
[X Link](https://x.com/3IDWarrant/status/1894372178490982559)  2025-02-25T13:01Z [--] followers, [---] engagements


"When you think $ARWR clearly has more room to run than $ALNY @Alnylam does @alnylam things if @ArrowheadPharma could ever be embraced as @alnylam.WATCH OUT"  
[X Link](https://x.com/3IDWarrant/status/1950906084652192057)  2025-07-31T13:07Z [---] followers, [---] engagements


"There comes a point in time that you just cannot deny @ArrowheadPharma stand out success across their buisness model of wholly owned & partnered drugs $AMGN $TAK $GSK $SRPT $NVS fully funded yet still holds an overwhelming amount of high potential clinical assets $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1963297427001061821)  2025-09-03T17:45Z [---] followers, [----] engagements


"After reading the amended $ARWR 10-K it seems @ArrowheadPharma needed to clear up anything left unsaid in regards to the professional afterlife of its officers primarily CEO as it pertains to unvested options. https://ir.arrowheadpharma.com/sec-filings/sec-filing/10-ka/0000879407-25-000013 https://ir.arrowheadpharma.com/sec-filings/sec-filing/10-ka/0000879407-25-000013"  
[X Link](https://x.com/3IDWarrant/status/1976977764998865275)  2025-10-11T11:46Z [---] followers, [---] engagements


"@hulksmash8181 @ArrowheadPharma Ambiguous yes it is. $ARWR has clearly been talking to a lot of parties on deals the timing and purpose of such clarity could have been for any number of reasons"  
[X Link](https://x.com/3IDWarrant/status/1977318208966115593)  2025-10-12T10:19Z [---] followers, [---] engagements


"@hulksmash8181 @ArrowheadPharma @jpmorgan Can you sell"  
[X Link](https://x.com/3IDWarrant/status/1980748600347963560)  2025-10-21T21:30Z [---] followers, [--] engagements


"@hulksmash8181 @ArrowheadPharma @jpmorgan That's wild"  
[X Link](https://x.com/3IDWarrant/status/1980751308748407084)  2025-10-21T21:41Z [---] followers, [--] engagements


"@hulksmash8181 @ArrowheadPharma @jpmorgan Sounds like there's little urgency to fix it"  
[X Link](https://x.com/3IDWarrant/status/1980752868748505288)  2025-10-21T21:47Z [---] followers, [--] engagements


"@drrichjlaw @Biotech2k1 $ARWR later stage pipeline & partners O plenty says they are up for the task.next $ALNY"  
[X Link](https://x.com/3IDWarrant/status/1981750801107231019)  2025-10-24T15:53Z [---] followers, [---] engagements


"@RNAiAnalyst So hard to believe $NVS & $ARWR didn't have more than a few conversations"  
[X Link](https://x.com/3IDWarrant/status/1982495411362582922)  2025-10-26T17:11Z [---] followers, [---] engagements


"$IONS Sure feels like the next large $XBI M&A snack.No position. $IONS $ALNY $ARWR siRNA"  
[X Link](https://x.com/3IDWarrant/status/1984932161502220532)  2025-11-02T10:34Z [---] followers, [---] engagements


"$SRPT Earnings PR "Three new research targets have been selected in addition to second-generation DM1 candidate selected at close of Arrowhead deal." $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1985456254395797519)  2025-11-03T21:17Z [---] followers, [---] engagements


"@auditor112017 @RNAiAnalyst I'll see your $IONS [--] month APOC3 dosing for sHTG and raise you $ARWR APOC3 & PCSK9 silencing in one shot for the lipid universe ๐Ÿคจ"  
[X Link](https://x.com/3IDWarrant/status/1988643739947225191)  2025-11-12T16:23Z [---] followers, [---] engagements


"$ARWR Over the top for the @ArrowheadPharma team God is good"  
[X Link](https://x.com/3IDWarrant/status/1990875178058813733)  2025-11-18T20:10Z [---] followers, [---] engagements


"@RNAiAnalyst @SuperDuperDrugs $ARWR upfront pricing transparency/Strategy should certainly win them some worthy competitor coin they already had the upper hand for numerous reasons classy. a gentleman's gentleman. $IONS"  
[X Link](https://x.com/3IDWarrant/status/1990893694208115017)  2025-11-18T21:23Z [---] followers, [---] engagements


"Running excessively low adoption rates of @ArrowheadPharma REDEMPLO for the sHTG target population is extremely eye opening $ARWR $NVS $AMGN $BMY $PFE $JNJ"  
[X Link](https://x.com/3IDWarrant/status/1994732296927346873)  2025-11-29T11:36Z [---] followers, [---] engagements


"@ArrowheadPharma CNS data looks nothing short of a gift from God himself. a BBB Crossing quarterly SubQ shot targetable to all brain regions.Priceless But im sure the market will figure something out ๐Ÿ˜…. $NVS did $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1998807357577626072)  2025-12-10T17:29Z [---] followers, [---] engagements


"You dont know until you know but $NVS stepped up for @ArrowheadPharma early days CNS TRIM with high praise & big bucks to a much larger extent than $AMGN did for LPa GalNAc. $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1999406719630274637)  2025-12-12T09:11Z [---] followers, [---] engagements


"$NVS Fiona Marshall PBR"We see Arrowheads TRiM technology as having great potential to achieve the type of widespread and effective delivery in key brain structures that will be necessary to see the full benefit of RNA medicines in neurodegeneration. $ARWR"  
[X Link](https://x.com/3IDWarrant/status/1999409241858187363)  2025-12-12T09:21Z [---] followers, [----] engagements


"The $NVS vetting engine that @ArrowheadPharma CNS TRIM impressed. Recommend the entire watch she is amazing Last [--] minutes is CLEAR.CLEAR.@Novartis has great interest in high caliber siRNA targeting. Her excitement as a scientist is palpable $ARWR https://youtu.be/uQHwN5d0w8csi=Tsu22ej0R8vksd_p https://youtu.be/uQHwN5d0w8csi=Tsu22ej0R8vksd_p"  
[X Link](https://x.com/3IDWarrant/status/1999419138939453903)  2025-12-12T10:00Z [---] followers, [----] engagements


"@AgarWoodCapital @realroseceline $ARWR probably worth another look considering price & timing GL"  
[X Link](https://x.com/3IDWarrant/status/2003456620010094940)  2025-12-23T13:24Z [---] followers, [---] engagements


"@Oligo_bio @BioBoyScout @medstudentinvst Maybe a DR question when both are so similar assuming price similarity as well. Would you want [--] or [--] month Follow ups with your patient $WVE $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2003527784510222792)  2025-12-23T18:07Z [---] followers, [---] engagements


"@Oligo_bio @BioBoyScout @medstudentinvst I feel like a strong case could be made for both but if insulin sensitivity or any metabolic abnormalities occur $WVE or $ARWR no way [--] month FU would be par for the course.couldn't be"  
[X Link](https://x.com/3IDWarrant/status/2003534136724849061)  2025-12-23T18:32Z [---] followers, [---] engagements


"@Oligo_bio @BioBoyScout @medstudentinvst chances of an absolutely clean label given the breath of the pop that doesnt require sooner than semi-annual follow up (for a number of reasons) probably will not happen for either $ARWR or $WVE so dosing [--] or [--] month SQ almost seems mute.no"  
[X Link](https://x.com/3IDWarrant/status/2003535123430437120)  2025-12-23T18:36Z [---] followers, [---] engagements


"@Oligo_bio @BioBoyScout @medstudentinvst Its certainly interesting to have such similar products headed toward a branded market. The data will certainly have to tell the tale of the tape $WVE $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2003536840041865687)  2025-12-23T18:43Z [---] followers, [---] engagements


"$ARWR Very intuitive Obesity trial designs by $ARWR designed to say a lot upfront with $LLY Tirzepatide https://t.co/Wlmn6VuwoT Very intuitive Obesity trial designs by $ARWR designed to say a lot upfront with $LLY Tirzepatide https://t.co/Wlmn6VuwoT"  
[X Link](https://x.com/3IDWarrant/status/2005974055174992223)  2025-12-30T12:07Z [---] followers, [----] engagements


"$ABVX careful with assumptions see below scenario that $ARWR CEO was slotted to speak at sounds pretty familiar.hindsight always 20/20 $ARWR CEO is the best qualified here Maybe we see something qualifying before OCT [--]. https://t.co/8UomGeZEbR https://t.co/x8mzWnKQds $ARWR CEO is the best qualified here Maybe we see something qualifying before OCT [--]. https://t.co/8UomGeZEbR https://t.co/x8mzWnKQds"  
[X Link](https://x.com/3IDWarrant/status/2005977033801887895)  2025-12-30T12:19Z [---] followers, [----] engagements


"@bill_us As a commercial bio $ARWR could surprise to the upside in [----] and still have plenty multi bagger left as it gets it's $ALNY legs under it post sHTG pull forward"  
[X Link](https://x.com/3IDWarrant/status/2006089060838736307)  2025-12-30T19:44Z [---] followers, [---] engagements


"@pawcio2009 Nice Thank you. Already submitted my primary pick. Suppose ill use my freebie to see if I can hit @ArrowheadPharma price again. I'll take $ARWR $180 And the final #biopick2025 award of the night goes to an individual that came closest to their eoy price target and it is: @3IDWarrant who came within 2% of his eoy price target with $arwr Congrats Chris you get an extra pick in [----] contest. Top 10: https://t.co/FZEgbVgpdk And the final #biopick2025 award of the night goes to an individual that came closest to their eoy price target and it is: @3IDWarrant who came within 2% of his"  
[X Link](https://x.com/3IDWarrant/status/2006493051745874136)  2025-12-31T22:29Z [---] followers, [----] engagements


"Just like [----] attainment of such a price will have little to do with my ability and everything to do with the grace of God blessing the work of @ArrowheadPharma. Don't kid yourself people this is biology.I hope it hits to the penny so we can have a worth while YE convo $ARWR @pawcio2009 Nice Thank you. Already submitted my primary pick. Suppose ill use my freebie to see if I can hit @ArrowheadPharma price again. I'll take $ARWR $180 @pawcio2009 Nice Thank you. Already submitted my primary pick. Suppose ill use my freebie to see if I can hit @ArrowheadPharma price again. I'll take $ARWR $180"  
[X Link](https://x.com/3IDWarrant/status/2007114902092341373)  2026-01-02T15:40Z [---] followers, [---] engagements


"@BioBoyScout Seems $ARWR gets kept on a tight leash so it doesn't grow into its nearly non transactable paternal brother $ALNY on anything other than the most modest DCF"  
[X Link](https://x.com/3IDWarrant/status/2007774813847429324)  2026-01-04T11:23Z [---] followers, [---] engagements


"@BioBoyScout Honest guess ill take Ted Tenthoff to be the first to get there around June if upcoming developments are positive $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2007775841548415190)  2026-01-04T11:27Z [---] followers, [---] engagements


"$ARWR very exciting a Pharmasette HCV type "test kitchen" PII would be amazing to explore the MANY possibilities these drugs could serve the various metabolically challenged patient landscape @ArrowheadPharma Bruce Givens dont go it's just getting exciting"  
[X Link](https://x.com/3IDWarrant/status/2008596173339398607)  2026-01-06T17:47Z [---] followers, [---] engagements


"$ARWR Absolute chimp off the Ole block"  
[X Link](https://x.com/3IDWarrant/status/2008598986480119984)  2026-01-06T17:58Z [---] followers, [---] engagements


"@fakepharmabro $ARWR re-issuing the $SRPT returned shares"  
[X Link](https://x.com/3IDWarrant/status/2008685747428016506)  2026-01-06T23:42Z [---] followers, [----] engagements


"Looks like @ArrowheadPharma made an enduring truce with this transaction $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2008688658040176864)  2026-01-06T23:54Z [---] followers, [---] engagements


"@MarkC_LVB @ArrowheadPharma The amount of paths to overwhelming success was palpable in the numerous disclosures "Nuggett Dropped" in yesterday's call. This timely raise will most likely give them independence from the capital markets $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2008924390134591715)  2026-01-07T15:31Z [---] followers, [---] engagements


"Shaping up to be another blowout YOY Quarter @ArrowheadPharma ๐Ÿ˜‚ That beat will erase this dip ๐Ÿป $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2008925566557179972)  2026-01-07T15:35Z [---] followers, [---] engagements


"Why does this feel like $ARWR proper is going to be for sale within the newly provided financial framework while @ArrowheadPharma select science emerges as a new animal"  
[X Link](https://x.com/3IDWarrant/status/2009213848092619195)  2026-01-08T10:41Z [---] followers, [----] engagements


"@pawcio2009 $SRPT"  
[X Link](https://x.com/3IDWarrant/status/2009358907966410794)  2026-01-08T20:17Z [---] followers, [---] engagements


"@RNAiAnalyst $ARWR stumbled onto something very interesting in T2D patients that if plays out in full data set will be an GLP1++ win for perscribers. Maybe leave MASH alone HSDB13"  
[X Link](https://x.com/3IDWarrant/status/2011050706829238594)  2026-01-13T12:20Z [---] followers, [---] engagements


"@jfais20 Highly doubt $ARWR would be interested anywhere near the status quo for reasons that make perfect sense as the CEO laid out @ JPM26.Que $WVE"  
[X Link](https://x.com/3IDWarrant/status/2011231117643563466)  2026-01-14T00:17Z [---] followers, [---] engagements


"@RNAiAnalyst $VRTX should certainly be interested"  
[X Link](https://x.com/3IDWarrant/status/2011941035874631797)  2026-01-15T23:18Z [---] followers, [--] engagements


"@RNAiAnalyst $ARWR science has truly continued to be an disregarded story that compounded looking more & more like an R&D wet dream lord willing"  
[X Link](https://x.com/3IDWarrant/status/2011397327194628470)  2026-01-14T11:17Z [---] followers, [---] engagements


"$ARWR JPM26: Ionis bolstered by strong launch of Tryngolza doubles its sales projection in new indication to $2B $IONS #pharma #RNA #pancreatitis #JPM26 https://t.co/VaVbW9KWE0 JPM26: Ionis bolstered by strong launch of Tryngolza doubles its sales projection in new indication to $2B $IONS #pharma #RNA #pancreatitis #JPM26 https://t.co/VaVbW9KWE0"  
[X Link](https://x.com/3IDWarrant/status/2011416083975356626)  2026-01-14T12:32Z [---] followers, [---] engagements


"@ArtsStocks @adamfeuerstein @FierceBiotech @BioPharmaDive While I appreciate protecting when feeling infringed. This only covers FCS patients and not SHTG truly even if $IONS had an amazing ruling what would they really win a couple million bucks @ 60K WAC per patient $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2011894559392088092)  2026-01-15T20:13Z [---] followers, [---] engagements


"Is there an expectation for $SRPT data on $ARWR muscle targeted therapies Monday @ JPM26"  
[X Link](https://x.com/3IDWarrant/status/2009961266190897358)  2026-01-10T12:11Z [---] followers, [---] engagements


"Great Biotech M&A Report just published by @PeterKolchinsky if not transacted within the next [--] months the below rapid acceleration posted in report maths out to a foregone conclusion on sHTG alone $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2010322619380465901)  2026-01-11T12:07Z [---] followers, [----] engagements


"Would love to see MC stretch goals in this year's @ArrowheadPharma 14A ๐Ÿคž $ARWR could be a year early but"  
[X Link](https://x.com/3IDWarrant/status/2014642227041997257)  2026-01-23T10:11Z [---] followers, [---] engagements


"@RNAiAnalyst Was thinking along similar lines regarding @ArrowheadPharma ALK7 and Hypothyroidism patients in regards strictly to fat storage from poor T3/T4 conversion $ARWR"  
[X Link](https://x.com/3IDWarrant/status/2017177220339376410)  2026-01-30T10:05Z [---] followers, [---] engagements


"@RNAiAnalyst @ArrowheadPharma It certainly is not even on hormone therapy it continues as a neglected downstream side effect that diet and exercise barely touch. So many other instances que the high cortisol staffer. $ARWR $WVE"  
[X Link](https://x.com/3IDWarrant/status/2017193925899882821)  2026-01-30T11:11Z [---] followers, [---] engagements


"The Matrix is becoming more transparent ๐Ÿซ  $ARWR Puts & Calls"  
[X Link](https://x.com/3IDWarrant/status/2018262018722021738)  2026-02-02T09:55Z [---] followers, [---] engagements


"@pt117cool $ARWR. Mike I saw something very similar before.The end story of $RLYP looked nearly identical it was DESTROYED in similar fashion by management & willing short sellers. Acquired"  
[X Link](https://x.com/3IDWarrant/status/1730521781859983837)  2023-12-01T09:38Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@3IDWarrant Avatar @3IDWarrant Chris

Chris posts on X about $arwr, $alny, $srpt, $nvs the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

Engagements: undefined #

Engagements Line Chart

  • [--] Week [---] -81%
  • [--] Month [-----] -68%
  • [--] Months [------] +46%
  • [--] Year [------] +37%

Mentions: undefined #

Mentions Line Chart

  • [--] Month [--] -86%
  • [--] Months [--] +30%
  • [--] Year [---] +8.30%

Followers: [---] #

Followers Line Chart

  • [--] Week [---] +0.59%
  • [--] Month [---] -0.58%
  • [--] Months [---] +60%
  • [--] Year [---] +98%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks 49% finance 5% cryptocurrencies 3% exchanges 1%

Social topic influence $arwr 90%, $alny 18%, $srpt 16%, $nvs 14%, $drna 10%, $ions 8%, $lly 8%, $wve 8%, arwr 8%, $nvo 5%

Top accounts mentioned or mentioned by @arrowheadpharma @rnaianalyst @hulksmash8181 @bioboyscout @bikerieder @oligobio @medstudentinvst @jpmorgan @pawcio2009 @elilillyandco @jmaraganore @wallstlobo @pt117cool @markclvb @biotech2k1 @mooktrader @mykec382023 @cloisterres @biomedicalrx @partimefriend

Top assets mentioned Arrowhead Research Corporation (ARWR) Alnylam Pharmaceuticals, Inc. (ALNY) Sarepta Therapeutics, Inc. (SRPT) Novartis AG (NVS) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Eli Lilly and Company (LLY) Wave Life Sciences Ltd. Ordinary Shares (WVE) Novo-Nordisk (NVO) Amgen, Inc. (AMGN) Abivax SA (ABVX) Smart Layer Network (SLN) Synthetify (SNY) Genelux Corporation (GNLX) Metsera, Inc. (MTSR) BEAM (BEAM) GSK plc (GSK) Bristol-Myers Squibb Co (BMY) Pfizer, Inc. (PFE) Johnson & Johnson (JNJ) Vertex Protocol (VRTX)

Top Social Posts

Top posts by engagements in the last [--] hours

"@EliLillyandCo scientist was pretty spot on [--] months ago describing the siRNA "Domino effect" for extra Hepatic delivery. @ArrowheadPharma has certainly proven out this rapid unlocking of tissue types like no other $ARWR $ALNY $IONS $SLN $LLY $NVO $NVS https://share.google/1yEyKlbXYXt0Sqk6s https://share.google/1yEyKlbXYXt0Sqk6s"
X Link 2026-01-16T11:03Z [---] followers, [----] engagements

"$ARWR CEO webcast 2.25B cash on hand.literally too many opportunities to speak on.Expect EU partner(s).God is amazing"
X Link 2026-01-12T16:13Z [---] followers, [----] engagements

"@RNAiAnalyst When I start to chase the wide array our bodies store fat the more and more the post GLP-1 world looks like it could be a botox type environment applicable to every person if interested for reason $WVE $ARWR"
X Link 2026-01-30T10:16Z [---] followers, [---] engagements

"@RNAiAnalyst Garnering 1-2B per target pretty much unanimously these days for an siRNA molecule it is still astounding to me that a more reputable RNAi co has not been transacted $ALNY $IONS $ARWR"
X Link 2026-02-02T19:22Z [---] followers, [----] engagements

"$ARWR $SRPT"
X Link 2025-06-24T11:40Z [---] followers, [----] engagements

"@MookTrader Nope Yet that market metrics has remained irrational longer than most have remained solvent time for betterment I suppose $ALNY $ARWR"
X Link 2025-06-24T20:04Z [---] followers, [---] engagements

"$SRPT is reinventing itself on the back of $ARWR talk about a dedicated partner moving forward"
X Link 2025-07-17T10:42Z [---] followers, [----] engagements

"Today watching $ARWR was the perfect example of how a stock can be manipulated down with little effort all but guaranteed those [--] calls are safe ๐Ÿ‘"
X Link 2025-07-18T19:57Z [---] followers, [---] engagements

"Interestingly enough if $SRPT & $ARWR deal were to be renegotiated $ARWR would walk away with exceptional terms on profit share without a doubt"
X Link 2025-07-20T00:30Z [---] followers, [----] engagements

"@MykeC382023 If $SRPT fate happens to be as you describe @ArrowheadPharma may have had the luckiest funding round in history if they see a return of assets $ARWR"
X Link 2025-07-20T01:31Z [---] followers, [---] engagements

"@CloisterRes That scenario that so many are calling likely for $SRPT would equate to the craziest bio bucks lotto win for $ARWR clinically derisked every day that goes by"
X Link 2025-07-23T21:29Z [---] followers, [---] engagements

"@JMaraganore Amazing problems to have $ALNY"
X Link 2025-08-01T13:45Z [---] followers, [---] engagements

"$SRPT guided lots & lots of siRNA data to close out [----] very excited to see how some of these programs perform in the clinic $ARWR"
X Link 2025-08-07T10:31Z [---] followers, [----] engagements

"@BiomedicalRX @ArrowheadPharma Anyone that was serious about an $ALNY BD Trans watched it stretch to the stratosphere no reason $ARWR with same capability can't achieve even 1/2 that (30B MC) in the coming years"
X Link 2025-08-08T16:42Z [---] followers, [---] engagements

"$LLY & $ALNY action seems about right"
X Link 2025-08-19T00:38Z [---] followers, [--] engagements

"Just Wow Congratulations @ArrowheadPharma $ARWR & $NVS coming together on a target is an amazing BD advancement for Arrowhead"
X Link 2025-09-02T12:15Z [---] followers, [---] engagements

"@RNAiAnalyst $NVS clearly see advantages with $ARWR CNS platform this certainly better validates to me that @ArrowheadPharma CEO talking about cracking the BBB has credence SubQ non the less"
X Link 2025-09-02T12:18Z [---] followers, [---] engagements

"Believe the $NVS $ARWR deal was to get the foot in the door for next year's sHTG readout I continue to believe more siRNA cardio drugs makes sense for $NVS to sell along side Leqvio"
X Link 2025-09-02T16:17Z [---] followers, [---] engagements

"Zero knock to $ALNY but seeing $SNY & $NVS willing to partner with both $ALNY & $ARWR makes me feel RNAi BD is no longer a winner-take-all space each has advanced the tech to provide a worthy investment from pharma"
X Link 2025-09-02T17:03Z [---] followers, [---] engagements

"NVS coming to $ARWR now for CNS validates for me the same way $AMGN came for Olpasiran in [----] im at an enjoy the bumpy ride up phase way too much unfolding over next [--] months just for @ArrowheadPharma let alone the partners who are clearly lining up to do buisness"
X Link 2025-09-03T00:53Z [---] followers, [----] engagements

"@RNAiAnalyst $NVS spread the wealth approach across various RNAi platform companies sure seems like they are digging in for longer term platform shopping their backseat very large entry has their hands in nearly every RNAi Co pocket $ARWR $ALNY $IONS"
X Link 2025-09-03T17:51Z [---] followers, [---] engagements

"@wallstlobo @hulksmash8181 If $ARWR CEO is correct (Cantor presentation) that most don't meet goal ( Trigs Below 880)on Olzarsiran then @ArrowheadPharma has great pricing power plus the "lead" will allow.did not meet trig goal to be established for payors. The lead may well work out nicely for $ARWR"
X Link 2025-09-05T13:12Z [---] followers, [---] engagements

"@Partimefriend @wallstlobo @hulksmash8181 @ArrowheadPharma @ArrowheadPharma CEO at Cantor made me think they may engage sHTG differently than previously thought CEO gave slight glimpse into a different angle they may explore to target a more narrow pop allowing price to remain high and be drug of choice $ARWR"
X Link 2025-09-05T15:05Z [---] followers, [---] engagements

"ARO-MAPT Will it work.man I hope so.the enabling of such advancements are undoubtedly the hand of God @ArrowheadPharma scientists are working $ARWR"
X Link 2025-09-10T12:05Z [---] followers, [---] engagements

"Congrats to @ArrowheadPharma previous VP of Finance $ARWR WESTLAKE VILLAGE Calif. Feb. [--] [----] (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX) a late clinical-stage immuno-oncology company today announced . https://finance.yahoo.com/news/genelux-corporation-announces-chief-financial-114500658.html https://finance.yahoo.com/news/genelux-corporation-announces-chief-financial-114500658.html"
X Link 2025-02-05T18:31Z [---] followers, [---] engagements

"$MTSR Now $ABVX the open dialogue that seems to be a near transparent process in M&A all off a sudden is an absolute welcome breath of fresh air ๐Ÿ˜…๐Ÿ˜…$XBI $IBB"
X Link 2025-12-24T23:22Z [---] followers, [---] engagements

"@RNAiAnalyst Reminds me of $DRNA after their PH readout followed by their acquisition. $ARWR"
X Link 2023-01-10T09:49Z [---] followers, [---] engagements

"@BikeRieder This is why personally speaking it's time to SUCCESSFULLY Exit and let a pharma take this modality where it wants to go. This story is inevitably turning into a $DRNA twin. $ARWR"
X Link 2023-06-07T09:34Z [---] followers, [---] engagements

"@BikeRieder Those are absolute facts leading to the here & now. How that potential is bargained/leveraged going forward to cover the finish is my $DRNA Comp"
X Link 2023-06-07T11:09Z [---] followers, [---] engagements

"Good $ALNY thread. They were clearly embraced as a WS darling your reasoning while sounding great never applied to $ARWR a near identical CO. Dangerous logic. 9) Upon further review I would edit my 15b comment on $BEAM and increase it to 20-25b. If $ALNY can hit close to 17b [--] years before any FDA approvals BEAM should be capable of 20-25b before their first approval. I do think NTLA will lead the next [--] yrs then BEAM will take over 9) Upon further review I would edit my 15b comment on $BEAM and increase it to 20-25b. If $ALNY can hit close to 17b [--] years before any FDA approvals BEAM should"
X Link 2023-08-29T22:52Z [---] followers, [----] engagements

"@TOWiU2 @1111DLH61 @RNAiAnalyst $ALNY & $DRNA $NVO Have now crossed the finish line. Fully acknowledge @ArrowheadPharma long road but there is no reason their FCS Drug not only gets there but establishes a high standard $ARWR"
X Link 2023-10-03T09:26Z [---] followers, [---] engagements

"I now view $LLY as another excellent move forward partner for $ARWR across their broad pipeline. Many synergies and left out in the $DRNA $NVO Marriage"
X Link 2023-10-05T10:47Z [---] followers, [---] engagements

"@pt117cool Those are all true but it is certainly worth more than $DRNA sale price with lung tox clearing the way and many late(r) stage assets $ARWR"
X Link 2023-11-30T15:21Z [---] followers, [---] engagements

"@RNAiAnalyst The way $NVS continues limping into RNAi while footing large pop Leqvio has made little sense to me as an "Efficiency" story. $ALNY & $ARWR a bridge too wide"
X Link 2024-01-13T09:29Z [---] followers, [---] engagements

"@RNAiAnalyst @biochemyst1 $LLY was a bidder for $DRNA but lost out to $NOVO what are your thoughts on $ALNY here"
X Link 2024-01-16T21:26Z [---] followers, [---] engagements

"@MarkC_LVB @JMaraganore @matthewherper @EliLillyandCo $LLY was a bidder in the $DRNA acquisition $ARWR"
X Link 2024-08-14T17:49Z [---] followers, [---] engagements

"@hulksmash8181 @RNAiAnalyst After $LLY missed out on $DRNA and one of @ArrowheadPharma lead siRNA scientists moved over some form of $ARWR relationship seemed in bound"
X Link 2024-11-07T16:21Z [---] followers, [---] engagements

"@Biotech2k1 @wkissel Does your analysis assign value only to clinical candidates If so I fully understand but the $11B $SRPT deal largely monetizes on the R&D side $ARWR At large can now R&D for specialty pharmas.or not the capacity is already built-in"
X Link 2024-12-03T09:55Z [---] followers, [---] engagements

"@WallStPirate We are like-minded in that same view fully funded with the $SRPT deal & NDA filed for a clear winner it's time for the science to take center stage $ARWR requires the patience of a corpse"
X Link 2024-12-07T09:29Z [---] followers, [---] engagements

"@hulksmash8181 With every day that goes by post the $SRPT deal such a low $ARWR valuation looks more and more attractive"
X Link 2024-12-11T22:42Z [---] followers, [---] engagements

"@BikeRieder It would be pretty wild if the $SRPT CEO ended up as the Chair of $ARWR Board"
X Link 2024-12-18T12:08Z [---] followers, [---] engagements

"@bioinvestor24 I don't know how $NVO is so "Lost" they bought $DRNA and have @ArrowheadPharma very talented old CSO it boggles me why they are not pushing next generation muscle sparring drugs into clinic via siRNA $ALNY $ARWR $WVE"
X Link 2025-01-02T12:50Z [---] followers, [---] engagements

"It feels like at large shorting across $XBI biotech names has ushered high complacency levels with very weak out dated narratives $ARWR prime example"
X Link 2025-02-12T16:13Z [--] followers, [----] engagements

"@hulksmash8181 @ArrowheadPharma currently sits at the highest institutional holding on record price should start to reflect such a following $ARWR"
X Link 2025-02-15T12:44Z [--] followers, [---] engagements

"@hulksmash8181 @ArrowheadPharma Apologies I meant holistically highest percentage being owned broadly by institutions overall percentage has never been this high clearly confidence & price need to talk and I'm sure they will $ARWR"
X Link 2025-02-15T15:10Z [--] followers, [---] engagements

"@ErvinBrent That's certainly interesting and could act as a pseudo buy back program supporting $ARWR if $SRPT likes what they see and the market continues to disregard @ArrowheadPharma"
X Link 2025-02-15T15:14Z [--] followers, [---] engagements

"@ArrowheadPharma ALK7 data released today further shows an undervalued bio that has been bruised battered & past over $ARWR"
X Link 2025-02-25T12:58Z [--] followers, [---] engagements

"@BikeRieder $ARWR has great potential to be a real next player in obesity with next gen compounds in addition to $NVO $LLY"
X Link 2025-02-25T13:01Z [--] followers, [---] engagements

"When you think $ARWR clearly has more room to run than $ALNY @Alnylam does @alnylam things if @ArrowheadPharma could ever be embraced as @alnylam.WATCH OUT"
X Link 2025-07-31T13:07Z [---] followers, [---] engagements

"There comes a point in time that you just cannot deny @ArrowheadPharma stand out success across their buisness model of wholly owned & partnered drugs $AMGN $TAK $GSK $SRPT $NVS fully funded yet still holds an overwhelming amount of high potential clinical assets $ARWR"
X Link 2025-09-03T17:45Z [---] followers, [----] engagements

"After reading the amended $ARWR 10-K it seems @ArrowheadPharma needed to clear up anything left unsaid in regards to the professional afterlife of its officers primarily CEO as it pertains to unvested options. https://ir.arrowheadpharma.com/sec-filings/sec-filing/10-ka/0000879407-25-000013 https://ir.arrowheadpharma.com/sec-filings/sec-filing/10-ka/0000879407-25-000013"
X Link 2025-10-11T11:46Z [---] followers, [---] engagements

"@hulksmash8181 @ArrowheadPharma Ambiguous yes it is. $ARWR has clearly been talking to a lot of parties on deals the timing and purpose of such clarity could have been for any number of reasons"
X Link 2025-10-12T10:19Z [---] followers, [---] engagements

"@hulksmash8181 @ArrowheadPharma @jpmorgan Can you sell"
X Link 2025-10-21T21:30Z [---] followers, [--] engagements

"@hulksmash8181 @ArrowheadPharma @jpmorgan That's wild"
X Link 2025-10-21T21:41Z [---] followers, [--] engagements

"@hulksmash8181 @ArrowheadPharma @jpmorgan Sounds like there's little urgency to fix it"
X Link 2025-10-21T21:47Z [---] followers, [--] engagements

"@drrichjlaw @Biotech2k1 $ARWR later stage pipeline & partners O plenty says they are up for the task.next $ALNY"
X Link 2025-10-24T15:53Z [---] followers, [---] engagements

"@RNAiAnalyst So hard to believe $NVS & $ARWR didn't have more than a few conversations"
X Link 2025-10-26T17:11Z [---] followers, [---] engagements

"$IONS Sure feels like the next large $XBI M&A snack.No position. $IONS $ALNY $ARWR siRNA"
X Link 2025-11-02T10:34Z [---] followers, [---] engagements

"$SRPT Earnings PR "Three new research targets have been selected in addition to second-generation DM1 candidate selected at close of Arrowhead deal." $ARWR"
X Link 2025-11-03T21:17Z [---] followers, [---] engagements

"@auditor112017 @RNAiAnalyst I'll see your $IONS [--] month APOC3 dosing for sHTG and raise you $ARWR APOC3 & PCSK9 silencing in one shot for the lipid universe ๐Ÿคจ"
X Link 2025-11-12T16:23Z [---] followers, [---] engagements

"$ARWR Over the top for the @ArrowheadPharma team God is good"
X Link 2025-11-18T20:10Z [---] followers, [---] engagements

"@RNAiAnalyst @SuperDuperDrugs $ARWR upfront pricing transparency/Strategy should certainly win them some worthy competitor coin they already had the upper hand for numerous reasons classy. a gentleman's gentleman. $IONS"
X Link 2025-11-18T21:23Z [---] followers, [---] engagements

"Running excessively low adoption rates of @ArrowheadPharma REDEMPLO for the sHTG target population is extremely eye opening $ARWR $NVS $AMGN $BMY $PFE $JNJ"
X Link 2025-11-29T11:36Z [---] followers, [---] engagements

"@ArrowheadPharma CNS data looks nothing short of a gift from God himself. a BBB Crossing quarterly SubQ shot targetable to all brain regions.Priceless But im sure the market will figure something out ๐Ÿ˜…. $NVS did $ARWR"
X Link 2025-12-10T17:29Z [---] followers, [---] engagements

"You dont know until you know but $NVS stepped up for @ArrowheadPharma early days CNS TRIM with high praise & big bucks to a much larger extent than $AMGN did for LPa GalNAc. $ARWR"
X Link 2025-12-12T09:11Z [---] followers, [---] engagements

"$NVS Fiona Marshall PBR"We see Arrowheads TRiM technology as having great potential to achieve the type of widespread and effective delivery in key brain structures that will be necessary to see the full benefit of RNA medicines in neurodegeneration. $ARWR"
X Link 2025-12-12T09:21Z [---] followers, [----] engagements

"The $NVS vetting engine that @ArrowheadPharma CNS TRIM impressed. Recommend the entire watch she is amazing Last [--] minutes is CLEAR.CLEAR.@Novartis has great interest in high caliber siRNA targeting. Her excitement as a scientist is palpable $ARWR https://youtu.be/uQHwN5d0w8csi=Tsu22ej0R8vksd_p https://youtu.be/uQHwN5d0w8csi=Tsu22ej0R8vksd_p"
X Link 2025-12-12T10:00Z [---] followers, [----] engagements

"@AgarWoodCapital @realroseceline $ARWR probably worth another look considering price & timing GL"
X Link 2025-12-23T13:24Z [---] followers, [---] engagements

"@Oligo_bio @BioBoyScout @medstudentinvst Maybe a DR question when both are so similar assuming price similarity as well. Would you want [--] or [--] month Follow ups with your patient $WVE $ARWR"
X Link 2025-12-23T18:07Z [---] followers, [---] engagements

"@Oligo_bio @BioBoyScout @medstudentinvst I feel like a strong case could be made for both but if insulin sensitivity or any metabolic abnormalities occur $WVE or $ARWR no way [--] month FU would be par for the course.couldn't be"
X Link 2025-12-23T18:32Z [---] followers, [---] engagements

"@Oligo_bio @BioBoyScout @medstudentinvst chances of an absolutely clean label given the breath of the pop that doesnt require sooner than semi-annual follow up (for a number of reasons) probably will not happen for either $ARWR or $WVE so dosing [--] or [--] month SQ almost seems mute.no"
X Link 2025-12-23T18:36Z [---] followers, [---] engagements

"@Oligo_bio @BioBoyScout @medstudentinvst Its certainly interesting to have such similar products headed toward a branded market. The data will certainly have to tell the tale of the tape $WVE $ARWR"
X Link 2025-12-23T18:43Z [---] followers, [---] engagements

"$ARWR Very intuitive Obesity trial designs by $ARWR designed to say a lot upfront with $LLY Tirzepatide https://t.co/Wlmn6VuwoT Very intuitive Obesity trial designs by $ARWR designed to say a lot upfront with $LLY Tirzepatide https://t.co/Wlmn6VuwoT"
X Link 2025-12-30T12:07Z [---] followers, [----] engagements

"$ABVX careful with assumptions see below scenario that $ARWR CEO was slotted to speak at sounds pretty familiar.hindsight always 20/20 $ARWR CEO is the best qualified here Maybe we see something qualifying before OCT [--]. https://t.co/8UomGeZEbR https://t.co/x8mzWnKQds $ARWR CEO is the best qualified here Maybe we see something qualifying before OCT [--]. https://t.co/8UomGeZEbR https://t.co/x8mzWnKQds"
X Link 2025-12-30T12:19Z [---] followers, [----] engagements

"@bill_us As a commercial bio $ARWR could surprise to the upside in [----] and still have plenty multi bagger left as it gets it's $ALNY legs under it post sHTG pull forward"
X Link 2025-12-30T19:44Z [---] followers, [---] engagements

"@pawcio2009 Nice Thank you. Already submitted my primary pick. Suppose ill use my freebie to see if I can hit @ArrowheadPharma price again. I'll take $ARWR $180 And the final #biopick2025 award of the night goes to an individual that came closest to their eoy price target and it is: @3IDWarrant who came within 2% of his eoy price target with $arwr Congrats Chris you get an extra pick in [----] contest. Top 10: https://t.co/FZEgbVgpdk And the final #biopick2025 award of the night goes to an individual that came closest to their eoy price target and it is: @3IDWarrant who came within 2% of his"
X Link 2025-12-31T22:29Z [---] followers, [----] engagements

"Just like [----] attainment of such a price will have little to do with my ability and everything to do with the grace of God blessing the work of @ArrowheadPharma. Don't kid yourself people this is biology.I hope it hits to the penny so we can have a worth while YE convo $ARWR @pawcio2009 Nice Thank you. Already submitted my primary pick. Suppose ill use my freebie to see if I can hit @ArrowheadPharma price again. I'll take $ARWR $180 @pawcio2009 Nice Thank you. Already submitted my primary pick. Suppose ill use my freebie to see if I can hit @ArrowheadPharma price again. I'll take $ARWR $180"
X Link 2026-01-02T15:40Z [---] followers, [---] engagements

"@BioBoyScout Seems $ARWR gets kept on a tight leash so it doesn't grow into its nearly non transactable paternal brother $ALNY on anything other than the most modest DCF"
X Link 2026-01-04T11:23Z [---] followers, [---] engagements

"@BioBoyScout Honest guess ill take Ted Tenthoff to be the first to get there around June if upcoming developments are positive $ARWR"
X Link 2026-01-04T11:27Z [---] followers, [---] engagements

"$ARWR very exciting a Pharmasette HCV type "test kitchen" PII would be amazing to explore the MANY possibilities these drugs could serve the various metabolically challenged patient landscape @ArrowheadPharma Bruce Givens dont go it's just getting exciting"
X Link 2026-01-06T17:47Z [---] followers, [---] engagements

"$ARWR Absolute chimp off the Ole block"
X Link 2026-01-06T17:58Z [---] followers, [---] engagements

"@fakepharmabro $ARWR re-issuing the $SRPT returned shares"
X Link 2026-01-06T23:42Z [---] followers, [----] engagements

"Looks like @ArrowheadPharma made an enduring truce with this transaction $ARWR"
X Link 2026-01-06T23:54Z [---] followers, [---] engagements

"@MarkC_LVB @ArrowheadPharma The amount of paths to overwhelming success was palpable in the numerous disclosures "Nuggett Dropped" in yesterday's call. This timely raise will most likely give them independence from the capital markets $ARWR"
X Link 2026-01-07T15:31Z [---] followers, [---] engagements

"Shaping up to be another blowout YOY Quarter @ArrowheadPharma ๐Ÿ˜‚ That beat will erase this dip ๐Ÿป $ARWR"
X Link 2026-01-07T15:35Z [---] followers, [---] engagements

"Why does this feel like $ARWR proper is going to be for sale within the newly provided financial framework while @ArrowheadPharma select science emerges as a new animal"
X Link 2026-01-08T10:41Z [---] followers, [----] engagements

"@pawcio2009 $SRPT"
X Link 2026-01-08T20:17Z [---] followers, [---] engagements

"@RNAiAnalyst $ARWR stumbled onto something very interesting in T2D patients that if plays out in full data set will be an GLP1++ win for perscribers. Maybe leave MASH alone HSDB13"
X Link 2026-01-13T12:20Z [---] followers, [---] engagements

"@jfais20 Highly doubt $ARWR would be interested anywhere near the status quo for reasons that make perfect sense as the CEO laid out @ JPM26.Que $WVE"
X Link 2026-01-14T00:17Z [---] followers, [---] engagements

"@RNAiAnalyst $VRTX should certainly be interested"
X Link 2026-01-15T23:18Z [---] followers, [--] engagements

"@RNAiAnalyst $ARWR science has truly continued to be an disregarded story that compounded looking more & more like an R&D wet dream lord willing"
X Link 2026-01-14T11:17Z [---] followers, [---] engagements

"$ARWR JPM26: Ionis bolstered by strong launch of Tryngolza doubles its sales projection in new indication to $2B $IONS #pharma #RNA #pancreatitis #JPM26 https://t.co/VaVbW9KWE0 JPM26: Ionis bolstered by strong launch of Tryngolza doubles its sales projection in new indication to $2B $IONS #pharma #RNA #pancreatitis #JPM26 https://t.co/VaVbW9KWE0"
X Link 2026-01-14T12:32Z [---] followers, [---] engagements

"@ArtsStocks @adamfeuerstein @FierceBiotech @BioPharmaDive While I appreciate protecting when feeling infringed. This only covers FCS patients and not SHTG truly even if $IONS had an amazing ruling what would they really win a couple million bucks @ 60K WAC per patient $ARWR"
X Link 2026-01-15T20:13Z [---] followers, [---] engagements

"Is there an expectation for $SRPT data on $ARWR muscle targeted therapies Monday @ JPM26"
X Link 2026-01-10T12:11Z [---] followers, [---] engagements

"Great Biotech M&A Report just published by @PeterKolchinsky if not transacted within the next [--] months the below rapid acceleration posted in report maths out to a foregone conclusion on sHTG alone $ARWR"
X Link 2026-01-11T12:07Z [---] followers, [----] engagements

"Would love to see MC stretch goals in this year's @ArrowheadPharma 14A ๐Ÿคž $ARWR could be a year early but"
X Link 2026-01-23T10:11Z [---] followers, [---] engagements

"@RNAiAnalyst Was thinking along similar lines regarding @ArrowheadPharma ALK7 and Hypothyroidism patients in regards strictly to fat storage from poor T3/T4 conversion $ARWR"
X Link 2026-01-30T10:05Z [---] followers, [---] engagements

"@RNAiAnalyst @ArrowheadPharma It certainly is not even on hormone therapy it continues as a neglected downstream side effect that diet and exercise barely touch. So many other instances que the high cortisol staffer. $ARWR $WVE"
X Link 2026-01-30T11:11Z [---] followers, [---] engagements

"The Matrix is becoming more transparent ๐Ÿซ  $ARWR Puts & Calls"
X Link 2026-02-02T09:55Z [---] followers, [---] engagements

"@pt117cool $ARWR. Mike I saw something very similar before.The end story of $RLYP looked nearly identical it was DESTROYED in similar fashion by management & willing short sellers. Acquired"
X Link 2023-12-01T09:38Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@3IDWarrant
/creator/twitter::3IDWarrant